Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]

Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N. Int J Chron Obstruct Pulmon Dis. 2021;16:579–589. The authors have advised that the statistical analysis script incorrectly labelled patients receiving ICS/LABA-combination inhalers as only receiving LABA. Th...

Full description

Bibliographic Details
Main Authors: Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
cardiovascular disease
exacerbations
statins
mortality
Online Access:https://www.dovepress.com/corrigendum-statins-in-high-risk-chronic-obstructive-pulmonary-disease-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/corrigendum-statins-in-high-risk-chronic-obstructive-pulmonary-disease-peer-reviewed-fulltext-article-COPD

Similar Items